Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Duensing

Showing results (71-80 of 139) with videos related to

Pageof 14
Sort By:
Oncogene|September 21, 2004
Cyclin-dependent kinase inhibitor indirubin-3'-oxime selectively inhibits human papillomavirus type 16 E7-induced numerical centrosome anomaliesStefan Duensing, Anette Duensing, David C Lee, et al.
Cancers|March 6, 2021
<i>miR-449a</i> Repression Leads to Enhanced NOTCH Signaling in <i>TMPRSS2:ERG</i> Fusion Positive Prostate Cancer CellsSimone Bauer, Leonie Ratz, Doreen Heckmann-Nötzel, et al.
Frontiers in Oncology|May 27, 2022
Kidney Cancer Models for Pre-Clinical Drug Discovery: Challenges and OpportunitiesLaura Pohl, Jana Friedhoff, Christina Jurcic, et al.
Oncotarget|April 28, 2017
TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cellsLeonie Ratz, Mark Laible, Lukasz A Kacprzyk, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|April 2, 2023
Senescent Tumor Cells Are Frequently Present at the Invasion Front: Implications for Improving Disease Control in Patients with Locally Advanced Prostate CancerSebastian Schwarz, Cathleen Nientiedt, Elena-Sophie Prigge, et al.
World Journal of Urology|December 28, 2013
The impact of type 2 diabetes on the outcome of localized renal cell carcinomaThomas Höfner, Martin Zeier, Gencay Hatiboglu, et al.
Urologic Oncology|June 16, 2014
Phenotypic drug screening and target validation for improved personalized therapy reveal the complexity of phenotype-genotype correlations in clear cell renal cell carcinomaMeike Schneider, Julia Schüler, Rouven Höfflin, et al.
Frontiers in Oncology|May 12, 2025
Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept studyJakob Wieke, Christina Jurcic, Adam Kaczorowski, et al.
Scientific Reports|August 31, 2024
Digital spatial profiling identifies the tumor center as a topological niche in prostate cancer characterized by an upregulation of BADAnn-Kathrin Huber, Adam Kaczorowski, Felix Schneider, et al.
Scientific Reports|July 10, 2021
Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladderGeorgi Tosev, Wasilijiang Wahafu, Philipp Reimold, et al.
Pageof 14

Showing results (71-80 of 139) with videos related to

Sort By:
Pageof 14
Oncogene|September 21, 2004
Cyclin-dependent kinase inhibitor indirubin-3'-oxime selectively inhibits human papillomavirus type 16 E7-induced numerical centrosome anomaliesStefan Duensing, Anette Duensing, David C Lee, et al.
Cancers|March 6, 2021
<i>miR-449a</i> Repression Leads to Enhanced NOTCH Signaling in <i>TMPRSS2:ERG</i> Fusion Positive Prostate Cancer CellsSimone Bauer, Leonie Ratz, Doreen Heckmann-Nötzel, et al.
Frontiers in Oncology|May 27, 2022
Kidney Cancer Models for Pre-Clinical Drug Discovery: Challenges and OpportunitiesLaura Pohl, Jana Friedhoff, Christina Jurcic, et al.
Oncotarget|April 28, 2017
TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cellsLeonie Ratz, Mark Laible, Lukasz A Kacprzyk, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|April 2, 2023
Senescent Tumor Cells Are Frequently Present at the Invasion Front: Implications for Improving Disease Control in Patients with Locally Advanced Prostate CancerSebastian Schwarz, Cathleen Nientiedt, Elena-Sophie Prigge, et al.
World Journal of Urology|December 28, 2013
The impact of type 2 diabetes on the outcome of localized renal cell carcinomaThomas Höfner, Martin Zeier, Gencay Hatiboglu, et al.
Urologic Oncology|June 16, 2014
Phenotypic drug screening and target validation for improved personalized therapy reveal the complexity of phenotype-genotype correlations in clear cell renal cell carcinomaMeike Schneider, Julia Schüler, Rouven Höfflin, et al.
Frontiers in Oncology|May 12, 2025
Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept studyJakob Wieke, Christina Jurcic, Adam Kaczorowski, et al.
Scientific Reports|August 31, 2024
Digital spatial profiling identifies the tumor center as a topological niche in prostate cancer characterized by an upregulation of BADAnn-Kathrin Huber, Adam Kaczorowski, Felix Schneider, et al.
Scientific Reports|July 10, 2021
Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladderGeorgi Tosev, Wasilijiang Wahafu, Philipp Reimold, et al.
Pageof 14